Centre proposes easier norms for faster drug rollout

India's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug regulator. Import license processing timelines for new drugs will be halved to forty-five days. This move aims to improve the ease of doing business in the sector. However, certain high-risk drug categories will retain existing stringent requirements.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cMTsGlP
via IFTTT